{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:36:17Z","timestamp":1759336577894,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["MNiSW\/2020\/357\/DIR","POIR.04.04.00-00-0004\/15"],"award-info":[{"award-number":["MNiSW\/2020\/357\/DIR","POIR.04.04.00-00-0004\/15"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114812","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T11:08:45Z","timestamp":1664881725000},"page":"114812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["4-Arylthiosemicarbazide derivatives \u2013 Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo"],"prefix":"10.1016","volume":"244","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-1074","authenticated-orcid":false,"given":"Adrian","family":"Bekier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Gatkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Chyb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Chwatko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"G\u0142owacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Paneth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Dzitko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"WHO, Multicriteria-Based Ranking for Risk Management of Food-Borne Parasites : Report of a Joint FAO\/WHO Expert Meeting, 3-7 September 2012, FAO Headquarters","author":"Boireau","key":"10.1016\/j.ejmech.2022.114812_bib1"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114812_bib2","article-title":"What constitutes a neglected tropical disease?","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114812_bib3","first-page":"898","article-title":"Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots","volume":"36","author":"Molan","year":"2019","journal-title":"Trop. Biomed."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib4","article-title":"The European union one health 2019 zoonoses report","volume":"19","author":"EFSA","year":"2021","journal-title":"EFSA J."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114812_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-020-3954-1","article-title":"The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967-2017): a systematic review and meta-analysis","volume":"13","author":"Montazeri","year":"2020","journal-title":"Parasites Vectors"},{"issue":"12\u201313","key":"10.1016\/j.ejmech.2022.114812_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114812_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.117790","article-title":"Geo-climatic factors and prevalence of chronic toxoplasmosis in pregnant women: a meta-analysis and meta-regression","volume":"288","author":"Rostami","year":"2021","journal-title":"Environ. Pollut."},{"article-title":"Congenital toxoplasmosis","year":"2021","series-title":"European Centre for Disease Prevention and Control . Annual Epidemiological Report for 2018, Annual Epidemiological Report on Communicable Diseases in Europe","key":"10.1016\/j.ejmech.2022.114812_bib9"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114812_bib10","first-page":"1368","article-title":"Anti-toxoplasmosis drugs","volume":"2","author":"Derouin","year":"2001","journal-title":"Curr. Opin. Invest. Drugs"},{"volume":"vol. 1","year":"2017","author":"Mayers","key":"10.1016\/j.ejmech.2022.114812_bib11"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114812_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9122531","article-title":"Toxoplasmosis: current and emerging parasite druggable targets","volume":"9","author":"Hajj","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2022.114812_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.02587","article-title":"Drug resistance in Toxoplasma gondii","volume":"9","author":"Montazeri","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114812_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.106180","article-title":"Ocular toxoplasmosis, an overview focusing on clinical aspects","volume":"225","author":"Fabiani","year":"2022","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molbiopara.2006.02.008","article-title":"Identification and expression analysis of ABC protein-encoding genes in Toxoplasma gondii. Toxoplasma gondii ATP-binding cassette superfamily","volume":"147","author":"Sauvage","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114812_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molbiopara.2003.08.015","article-title":"P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii","volume":"134","author":"Sauvage","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114812_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010062","article-title":"The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii","volume":"5","author":"Bottova","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114812_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1017\/S0031182014000481","article-title":"Veterinary vaccines against toxoplasmosis","volume":"141","author":"Hiszczy\u0144ska-Sawicka","year":"2014","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114812_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Expet Opin. Biol. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114812_bib20","article-title":"Advances in Toxoplasma gondii vaccines: current strategies and challenges for vaccine development","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114812_bib21","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"14","key":"10.1016\/j.ejmech.2022.114812_bib22","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1017\/S0031182013001169","article-title":"Evidence of the three main clonal Toxoplasma gondii lineages from wild mammalian carnivores in the UK","volume":"140","author":"Burrells","year":"2013","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114812_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S0031182013001844","article-title":"Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping","volume":"141","author":"Shwab","year":"2014","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114812_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030614","article-title":"Systematic identification of thiosemicarbazides for inhibition of Toxoplasma gondii growth in vitro","volume":"24","author":"Paneth","year":"2019","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejmech.2022.114812_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24081618","article-title":"Discovery of potent and selective halogen-substituted imidazole-thiosemicarbazides for inhibition of Toxoplasma gondii growth in vitro via structure-based design","volume":"24","author":"Paneth","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114812_bib26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14756366.2021.1931164","article-title":"4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents","volume":"36","author":"Bekier","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114812_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063213","article-title":"4-Arylthiosemicarbazide derivatives as toxoplasmic aromatic amino acid hydroxylase inhibitors and anti-inflammatory agents","volume":"23","author":"Bekier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114812_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0020-7519(01)00321-6","article-title":"Genetic analysis of influences on survival following Toxoplasma gondii infection","volume":"32","author":"Johnson","year":"2002","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3181\/00379727-79-19354","article-title":"Thiosemicarbazide toxicity in mice","volume":"79","author":"Parks","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114812_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.2042-7158.1969.tb08137.x","article-title":"Enhancement of the convulsant action of thiosemicarbazide in mice","volume":"21","author":"Mennear","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114812_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpba.2015.08.032","article-title":"Preclinical pharmacokinetics, tissue distribution and excretion studies of a novel anti-candidal agent-thiosemicarbazide derivative of isoniazid (TSC-INH) by validated UPLC-MS\/MS assay","volume":"117","author":"Iqbal","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"15","key":"10.1016\/j.ejmech.2022.114812_bib33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3748\/wjg.15.1863","article-title":"Non-alcoholic steatohepatitis with normal aminotransferase values","volume":"15","author":"Uslusoy","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2022.114812_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109742","article-title":"Synthesis, characterization, DFT calculation, antioxidant activity, ADMET and molecular docking of thiosemicarbazide derivatives and their Cu (II) complexes","volume":"351","author":"Mermer","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2022.114812_bib35","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00044-021-02756-z","article-title":"Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions","volume":"30","author":"Sicak","year":"2021","journal-title":"Med. Chem. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114812_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.184.2.597","article-title":"Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii","volume":"184","author":"Liesenfeld","year":"1996","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114812_bib37","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.4049\/jimmunol.177.12.8785","article-title":"Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii","volume":"177","author":"Heimesaat","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114812_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204895","article-title":"Toxoplasma gondii infection triggers chronic cachexia and sustained commensal dysbiosis in mice","volume":"13","author":"Hatter","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114812_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fcimb.2017.00116","article-title":"Chronic Toxoplasma gondii infection exacerbates secondary polymicrobial sepsis","volume":"7","author":"Souza","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114812_bib40","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/jm950760y","article-title":"Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations","volume":"39","author":"Piper","year":"1996","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114812_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123476","article-title":"Imidazole-thiosemicarbazide derivatives as potent anti-Mycobacterium tuberculosis compounds with antibiofilm activity","volume":"10","author":"Bekier","year":"2021","journal-title":"Cells"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:52:59Z","timestamp":1759330379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422007140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":41,"alternative-id":["S0223523422007140"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114812","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Arylthiosemicarbazide derivatives \u2013 Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114812"}}